A new publication on the possible effect of CBD for neuropsychiatric disorders
From the publication:
Cannabinoids in OtherNeuropsychiatric Disorders
Cannabidiol has been evaluated as a therapy for other
neurologic and psychiatric conditions. Some of these disorders,
such as neonatal hypoxic-ischemic encephalopathy,
can be associated with seizures. Other disorders, such as
anxiety and psychosis, are often comorbid conditions in
PWE. Activity of CBD in conditions that may lead to epilepsy
or coexist with epilepsy make it an attractive therapeutic
compound because of its potential to affect the
underlying epileptogenic process or target some of the additional
disabling symptoms of the disease.
For the publication click HERE